Myasthenia gravis: prototype of the antireceptor autoimmune diseases.
Schönbeck
S
S
Department of Neurology, University of Munich, Federal Republic of Germany.
Chrestel
S
S
Hohlfeld
R
R
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001323:Autoantibodies / Q000276:immunology / Q000378:metabolism; D001327:Autoimmune Diseases / Q000276:immunology*; D002038:Bungarotoxins / Q000378:metabolism; D003131:Combined Modality Therapy; D004195:Disease Models, Animal; D000939:Epitopes / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D015640:Ion Channel Gating; D008954:Models, Biological; D009157:Myasthenia Gravis / Q000276:immunology* / Q000628:therapy; D009469:Neuromuscular Junction / Q000503:physiopathology; D011817:Rabbits; D011950:Receptors, Cholinergic / Q000276:immunology / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000276:immunology* / Q000378:metabolism; D013329:Structure-Activity Relationship; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D013950:Thymus Gland / Q000503:physiopathology; D014101:Torpedo / Q000276:immunology / Q000378:metabolism; D064569:alpha7 Nicotinic Acetylcholine Receptor
D001323:Autoantibodies; D002038:Bungarotoxins; C579167:Chrna7 protein, human; D000939:Epitopes; D011950:Receptors, Cholinergic; D011978:Receptors, Nicotinic; D064569:alpha7 Nicotinic Acetylcholine Receptor; D000109:Acetylcholine